Get the latest news, insights, and market updates on DOCS (Doximity, Inc.). Explore the news page 5 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.
Morgan Stanley Stays Neutral on Doximity, Highlights Strength in Video Module Business
Doximity, Inc. (NYSE:DOCS) is one of the best digital health stocks to buy now. On November 3, 2025, Morgan Stanley maintained its Equal-Weight rating on Doximity and held its price target steady at $62. The firm’s analyst Craig Hettenbach cited third-quarter checks indicating stronger-than-expected growth, driven in large part by the company’s video module business. […] Nov 16, 2025 - $DOCS
Jim Cramer Says Doximity is “Still Too Expensive”
Doximity, Inc. (NYSE:DOCS) is one of the stocks Jim Cramer mentioned in his latest comments. During the lightning round, a caller mentioned that they were not sure if they should sell their position in the stock, and Cramer replied: “No, no, it’s still too expensive, and I didn’t think the quarter was as good as […] Nov 14, 2025 - $DOCS
5 Must-Read Analyst Questions From Doximity’s Q3 Earnings Call
Doximity’s third quarter results were marked by strong revenue and profit outperformance relative to Wall Street expectations, yet the market responded negatively. Management attributed the quarter’s performance to rapid adoption of AI-powered workflow products, integration of the Pathway acquisition, and a shift in customer upsell timing. CEO Jeffrey Tangney highlighted surging engagement with new features, particularly the AI scribe and DoxGPT tools, which saw user numbers rise sharply. CFO An Nov 13, 2025 - $DOCS
1 of Wall Street’s Favorite Stock to Target This Week and 2 We Brush Off
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory. Nov 10, 2025 - $DOCS
Examining Doximity’s Valuation After a 26% Drop Amid Telehealth Sector Headlines
Thinking about whether Doximity is undervalued or primed for growth? You are not alone, and it is a great time to dig deeper into what is driving the stock’s current worth. The share price has moved significantly recently, with Doximity down 17.7% in the last week and 26.2% over the past month. However, the stock remains up 1.4% year-to-date and 55.4% over three years. Healthcare technology headlines continue to play an important role, particularly as investors respond to sector shifts and... Nov 8, 2025 - $DOCS
DOCS Q3 Deep Dive: AI Integration and Upsell Timing Drive Revenue, Margin Pressures Emerge
Medical professional network Doximity (NYSE:DOCS) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 23.2% year on year to $168.5 million. The company expects next quarter’s revenue to be around $180.5 million, close to analysts’ estimates. Its non-GAAP profit of $0.45 per share was 18.7% above analysts’ consensus estimates. Nov 7, 2025 - $DOCS
Compared to Estimates, Doximity (DOCS) Q2 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Doximity (DOCS) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. Nov 7, 2025 - $DOCS
We use cookies and similar technologies to collect and process data such as browsing activity or unique identifiers.
Selecting "Allow All" to help us understand site usage and improve the platform.
Choosing "Essential Cookies Only" enables only the cookies necessary for core site functions, such as staying logged in.
For more information, please see our Privacy Policy.
Continue with Google
Continue with Facebook
Continue with Microsoft
Continue with Apple